YIFAN BIOTECHNOLOGY GROUP CO., LTD – Trademark Portfolio
Entity Type: 99
YIFAN BIOTECHNOLOGY GROUP CO., LTD holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 9 trademarks are registered and 1 is pending. Notable registered marks include FRIGATE, WIDESEA, LONGWIND, NEATLAND, and BLASTWAVE. The owner is based in Wenzhou, Zhejiang.
Yaoxi Subdistrict, longwan District
No.555, Changan Road
Wenzhou, Zhejiang 325013 , CN
Showing of trademarks Trademarks
Trademark Classifications
YIFAN BIOTECHNOLOGY GROUP CO., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does YIFAN BIOTECHNOLOGY GROUP CO., LTD have?
YIFAN BIOTECHNOLOGY GROUP CO., LTD has 12 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 pending, 2 abandoned.
What trademark classes does YIFAN BIOTECHNOLOGY GROUP CO., LTD file in?
YIFAN BIOTECHNOLOGY GROUP CO., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are YIFAN BIOTECHNOLOGY GROUP CO., LTD's most well-known trademarks?
YIFAN BIOTECHNOLOGY GROUP CO., LTD's registered trademark portfolio includes well-known marks such as FRIGATE, WIDESEA, LONGWIND, NEATLAND, and BLASTWAVE. These are among 9 currently registered trademarks in the portfolio.
What is YIFAN BIOTECHNOLOGY GROUP CO., LTD's trademark registration success rate?
YIFAN BIOTECHNOLOGY GROUP CO., LTD has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.